ImmuCell Corporation Property, Plant and Equipment, Gross, Period Increase (Decrease)
ImmuCell Corporation (ICCC) reported Property, Plant and Equipment, Gross, Period Increase (Decrease) of $13.93 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Notes › and Equipment
us-gaap:PropertyPlantAndEquipmentGrossPeriodIncreaseDecrease · last filed 2017-11-13
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for the quarter ending 2017-03-31 was $4.10M, a 655.98% increase year-over-year.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for the quarter ending 2016-12-31 was $2.79M, a 208.35% increase year-over-year.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for the quarter ending 2016-09-30 was $882.19K, a 290.24% increase year-over-year.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for the quarter ending 2016-06-30 was $607.34K, a 130.23% increase year-over-year.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for fiscal 2016 was $4.83M, a 120.80% increase from fiscal 2015.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for fiscal 2015 was $2.19M, a 25.12% increase from fiscal 2014.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for fiscal 2014 was $1.75M, a 387.23% increase from fiscal 2013.
- ImmuCell Corporation property, plant and equipment, gross, period increase (decrease) for fiscal 2013 was $358.53K.
| Period end | Property, Plant and Equipment, Gross, Period Increase (Decrease) 3 month | Property, Plant and Equipment, Gross, Period Increase (Decrease) 6 month | Property, Plant and Equipment, Gross, Period Increase (Decrease) 9 month | Property, Plant and Equipment, Gross, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2017-09-30 | $13.93M 10-Q · filed 2017-11-13 | |||
| 2017-03-31 | $4.10M 10-Q · filed 2017-05-11 | $6.90M derived: sum of 2 quarters · filed 2017-05-11 | $7.78M derived: sum of 3 quarters · filed 2017-05-11 | $8.38M derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $3.68M derived: sum of 2 quarters · filed 2017-03-30 | $4.28M derived: sum of 3 quarters · filed 2017-03-30 | $4.83M 10-K · filed 2017-03-30 |
| 2016-09-30 | $882.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.49M derived: sum of 2 quarters · filed 2016-11-10 | $2.03M 10-Q · filed 2016-11-10 | $2.94M derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | $607.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $1.15M 10-Q · filed 2016-08-11 | $2.06M derived: sum of 3 quarters · filed 2016-08-11 | $2.28M derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | $542.52K 10-Q · filed 2016-05-11 | $1.45M derived: sum of 2 quarters · filed 2016-05-11 | $1.67M derived: sum of 3 quarters · filed 2016-05-11 | $1.94M derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-12-31 | $906.16K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $1.13M derived: sum of 2 quarters · filed 2016-03-25 | $1.40M derived: sum of 3 quarters · filed 2016-03-25 | $2.19M 10-K · filed 2016-03-25 |
| 2015-09-30 | $226.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $489.86K derived: sum of 2 quarters · filed 2015-11-12 | $1.28M 10-Q · filed 2015-11-12 | $2.44M derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | $263.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.05M 10-Q · filed 2015-08-13 | $2.21M derived: sum of 3 quarters · filed 2015-08-13 | $2.52M derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | $789.70K 10-Q · filed 2015-05-12 | $1.95M derived: sum of 2 quarters · filed 2015-05-12 | $2.26M derived: sum of 3 quarters · filed 2015-05-12 | $2.31M derived: sum of 4 quarters · filed 2015-05-12 |
| 2014-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $1.47M derived: sum of 2 quarters · filed 2015-03-26 | $1.52M derived: sum of 3 quarters · filed 2015-03-26 | $1.75M 10-K · filed 2015-03-26 |
| 2014-09-30 | $310.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $356.89K derived: sum of 2 quarters · filed 2014-11-12 | $587.60K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $46.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $276.87K 10-Q · filed 2014-08-13 | ||
| 2014-03-31 | $230.71K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $358.53K 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |